Skip to content

Clinical trials

Phase 2 Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 2 Country / region: United States Clear all

310 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
20016
20027
200315
200412
200513
200610
200714
200812
20099
201012
20116
20128
20134
20145
201513
20168
201713
201810
201914
202015
202112
20226
20237
20244
202510
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed177
Terminated40
Active, not recruiting40
Recruiting28
Unknown status13
Withdrawn9
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)55
Memorial Sloan Kettering Cancer Center34
M.D. Anderson Cancer Center12
Gynecologic Oncology Group10
Dana-Farber Cancer Institute9
Washington University School of Medicine8
Children's Oncology Group7
City of Hope Medical Center6
H. Lee Moffitt Cancer Center and Research Institute6
Sarcoma Alliance for Research through Collaboration6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma310
Osteosarcoma54
Rhabdomyosarcoma44
Neuroectodermal Tumors, Primitive, Peripheral38
Neuroblastoma36
Liposarcoma30
Wilms Tumor30
Leiomyosarcoma29
Ovarian Neoplasms28
Sarcoma, Ewing27

Trials

Showing 1 to 25 of 310. Each trial links to its page on Pharma Observatory.

210 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.